Conflicting results emerged from a randomized, double-blind, placebo-controlled rhGH treatment study, which showed, in fifty CHF patients, an increase in LV mass related to serum IGF-1 level but no change in LV wall stress, arterial blood pressure, ejection fraction, clinical status or 6-minute walking distance [205]. Here, IGF1 is linked to congestive heart failure.